Foster CC, Couey MA, Kochanny SE, Khattri A, et al. Immune-related adverse events are associated with improved response,
progression-free survival, and overall survival for patients with head and neck
cancer receiving immune checkpoint inhibitors. Cancer 2021 Sep 21. doi: 10.1002/cncr.33780.
PMID: 34547103